Short description
Canadian clinical-stage biopharmaceutical company
Description
Vitaeris has licensed global exclusive rights to the best-in-class anti-interleukin-6 monoclonal antibody Clazakizumab from Alder Biopharmaceuticals, and is actively pursuing innovative applications in chronic inflammatory diseases.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Vancouver, British Columbia, Canada, North America
Founded on
January 1, 2016
Exited on
June 8, 2020
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Kevin Chow, Noel Hall, Patrick Robinson